{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:54:15Z","timestamp":1791986055414,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI51794"],"award-info":[{"award-number":["AI51794"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["D43TW00231"],"award-info":[{"award-number":["D43TW00231"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","award":["67385"],"award-info":[{"award-number":["67385"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["96354"],"award-info":[{"award-number":["96354"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["MRC-RFA-UFSP-01-2013\/UKZN-HIVEPI"],"award-info":[{"award-number":["MRC-RFA-UFSP-01-2013\/UKZN-HIVEPI"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Contraception Research and Development","award":["GP00-08-00005-00"],"award-info":[{"award-number":["GP00-08-00005-00"]}]},{"name":"Contraception Research and Development","award":["PPA-09-046"],"award-info":[{"award-number":["PPA-09-046"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-2961-8","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T17:22:47Z","timestamp":1516900967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Case report: mechanisms of HIV elite control in two African women"],"prefix":"10.1186","volume":"18","author":[{"given":"Yumna","family":"Moosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramla F.","family":"Tanko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veron","family":"Ramsuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashudu","family":"Madzivhandila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonhlanhla","family":"Yende-Zuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa-Rose","family":"Abrahams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Selhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamini","family":"Gounder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny L.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim S.","family":"Abdool Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel J.","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3396-9398","authenticated-orcid":false,"given":"Wendy A.","family":"Burgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"issue":"1","key":"2961_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1517\/14712590802571928","volume":"9","author":"BM Baker","year":"2009","unstructured":"Baker BM, Block BL, Rothchild AC, Walker BD. Elite control of HIV infection: implications for vaccine design. Expert Opin Biol Ther. 2009;9(1):55\u201369.","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"2961_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1086\/653678","volume":"51","author":"M Saag","year":"2010","unstructured":"Saag M, Deeks SG. How do HIV elite controllers do what they do? Clin Infect Dis. 2010;51(2):239\u201341.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2961_CR3","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1128\/JVI.02165-06","volume":"81","author":"JN Blankson","year":"2007","unstructured":"Blankson JN, Bailey JR, Thayil S, Yang HC, Lassen K, Lai J, et al. Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. J Virol. 2007;81(5):2508\u201318.","journal-title":"J Virol"},{"issue":"9","key":"2961_CR4","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/cid\/ciu573","volume":"59","author":"K Mlisana","year":"2014","unstructured":"Mlisana K, Werner L, Garrett NJ, McKinnon LR, van Loggerenberg F, Passmore JA, et al. Rapid disease progression in HIV-1 subtype C-infected south African women. Clin Infect Dis. 2014;59(9):1322\u201331.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2961_CR5","doi-asserted-by":"publisher","first-page":"e1954","DOI":"10.1371\/journal.pone.0001954","volume":"3","author":"F van Loggerenberg","year":"2008","unstructured":"van Loggerenberg F, Mlisana K, Williamson C, Auld SC, Morris L, Gray CM, et al. Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study. PLoS One. 2008;3(4):e1954.","journal-title":"PLoS One"},{"issue":"11","key":"2961_CR6","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1086\/646609","volume":"200","author":"JF Okulicz","year":"2009","unstructured":"Okulicz JF, Marconi VC, Landrum ML, Wegner S, Weintrob A, Ganesan A, et al. Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of defense HIV natural history study. J Infect Dis. 2009;200(11):1714\u201323.","journal-title":"J Infect Dis"},{"issue":"5996","key":"2961_CR7","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.1193748","volume":"329","author":"Q Abdool Karim","year":"2010","unstructured":"Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168\u201374.","journal-title":"Science"},{"issue":"8","key":"2961_CR8","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.4049\/jimmunol.0803801","volume":"182","author":"WA Burgers","year":"2009","unstructured":"Burgers WA, Riou C, Mlotshwa M, Maenetje P, de Assis RD, Brenchley J, et al. Association of HIV-specific and total CD8+ T memory phenotypes in subtype C HIV-1 infection with viral set point. J Immunol. 2009;182(8):4751\u201361.","journal-title":"J Immunol"},{"issue":"6929","key":"2961_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature01470","volume":"422","author":"X Wei","year":"2003","unstructured":"Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, et al. Antibody neutralization and escape by HIV-1. Nature. 2003;422(6929):307\u201312.","journal-title":"Nature"},{"issue":"10","key":"2961_CR10","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1128\/JVI.00198-11","volume":"85","author":"ES Gray","year":"2011","unstructured":"Gray ES, Madiga MC, Hermanus T, Moore PL, Wibmer CK, Tumba NL, et al. HIV-1 neutralization breadth develops incrementally over 4 years and is associated with CD4+ T cell decline and high viral load during acute infection. J Virol. 2011;85(10):4828\u201340.","journal-title":"J Virol"},{"issue":"6","key":"2961_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ng2035","volume":"39","author":"MP Martin","year":"2007","unstructured":"Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet. 2007;39(6):733\u201340.","journal-title":"Nat Genet"},{"issue":"8","key":"2961_CR12","doi-asserted-by":"publisher","first-page":"e71758","DOI":"10.1371\/journal.pone.0071758","volume":"8","author":"DR Chopera","year":"2013","unstructured":"Chopera DR, Mann JK, Mwimanzi P, Omarjee S, Kuang XT, Ndabambi N, et al. No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial. PLoS One. 2013;8(8):e71758.","journal-title":"PLoS One"},{"issue":"8","key":"2961_CR13","doi-asserted-by":"publisher","first-page":"e01806","DOI":"10.1128\/JVI.01806-16","volume":"91","author":"P Selhorst","year":"2017","unstructured":"Selhorst P, Combrinck C, Ndabambi N, Ismail SD, Abrahams MR, Lacerda M, et al. Replication capacity of viruses from acute infection drives HIV-1 disease progression. J Virol. 2017;91(8):e01806\u201316.","journal-title":"J Virol"},{"issue":"4","key":"2961_CR14","doi-asserted-by":"publisher","first-page":"e55943","DOI":"10.1371\/journal.pone.0055943","volume":"8","author":"MC Strain","year":"2013","unstructured":"Strain MC, Lada SM, Luong T, Rought SE, Gianella S, Terry VH, et al. Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One. 2013;8(4):e55943.","journal-title":"PLoS One"},{"issue":"8","key":"2961_CR15","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nri2357","volume":"8","author":"PJ Goulder","year":"2008","unstructured":"Goulder PJ, Watkins DI. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol. 2008;8(8):619\u201330.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2961_CR16","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.chom.2014.05.011","volume":"15","author":"J Leng","year":"2014","unstructured":"Leng J, Ho HP, Buzon MJ, Pereyra F, Walker BD, Yu XG, et al. A cell-intrinsic inhibitor of HIV-1 reverse transcription in CD4(+) T cells from elite controllers. Cell Host Microbe. 2014;15(6):717\u201328.","journal-title":"Cell Host Microbe"},{"issue":"6","key":"2961_CR17","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.161.6.3195","volume":"161","author":"MA Ostrowski","year":"1998","unstructured":"Ostrowski MA, Justement SJ, Catanzaro A, Hallahan CA, Ehler LA, Mizell SB, et al. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J Immunol. 1998;161(6):3195\u2013201.","journal-title":"J Immunol"},{"issue":"1","key":"2961_CR18","doi-asserted-by":"publisher","first-page":"e86719","DOI":"10.1371\/journal.pone.0086719","volume":"9","author":"AD Olson","year":"2014","unstructured":"Olson AD, Meyer L, Prins M, Thiebaut R, Gurdasani D, Guiguet M, et al. An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration. PLoS One. 2014;9(1):e86719.","journal-title":"PLoS One"},{"issue":"27","key":"2961_CR19","doi-asserted-by":"publisher","first-page":"8379","DOI":"10.1073\/pnas.1501443112","volume":"112","author":"PJ Kuebler","year":"2015","unstructured":"Kuebler PJ, Mehrotra ML, McConnell JJ, Holditch SJ, Shaw BI, Tarosso LF, et al. Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial. Proc Natl Acad Sci. 2015;112(27):8379\u201384.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"2961_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/QAI.0000000000000923","volume":"72","author":"PJ Kuebler","year":"2016","unstructured":"Kuebler PJ, Shaw BI, Leadabrand KS, Mehrotra ML, Grant RM, Kall\u00e1s EG, Nixon DF. HIV-1 gp120 T-cell responses correspond to infection outcomes in the global iPrEx chemoprophylaxis trial. J Acquir Immune Defic Syndr. 2016;72(2):184\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"2961_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1086\/526786","volume":"197","author":"F Pereyra","year":"2008","unstructured":"Pereyra F, Addo MM, Kaufmann DE, Liu Y, Miura T, Rathod A, et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis. 2008;197(4):563\u201371.","journal-title":"J Infect Dis"},{"issue":"8","key":"2961_CR22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/QAD.0b013e328329f97d","volume":"23","author":"O Lambotte","year":"2009","unstructured":"Lambotte O, Ferrari G, Moog C, Yates NL, Liao HX, Parks RJ, et al. Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS. 2009;23(8):897\u2013906.","journal-title":"AIDS"},{"key":"2961_CR23","doi-asserted-by":"crossref","unstructured":"Freund NT, Wang H, Scharf L, Nogueira L, Horwitz JA, Bar-On Y, et al. Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller. Sci Transl Med. 2017;9(373):eaal2144.","DOI":"10.1126\/scitranslmed.aal2144"},{"issue":"1\u20134","key":"2961_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000184703","volume":"123","author":"T Nakajima","year":"2008","unstructured":"Nakajima T, Kaur G, Mehra N, Kimura A. HIV-1\/AIDS susceptibility and copy number variation in CCL3L1, a gene encoding a natural ligand for HIV-1 co-receptor CCR5. Cytogenet Genome Res. 2008;123(1\u20134):156\u201360.","journal-title":"Cytogenet Genome Res"},{"issue":"11","key":"2961_CR25","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1093\/jac\/dku276","volume":"69","author":"E Riveira-Mu\u00f1oz","year":"2014","unstructured":"Riveira-Mu\u00f1oz E, Ruiz A, Pauls E, Permanyer M, Badia R, Mothe B, et al. Increased expression of SAMHD1 in a subset of HIV-1 elite controllers. J Antimicrob Chemother. 2014;69(11):3057\u201360.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"2961_CR26","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1128\/JVI.03464-14","volume":"89","author":"T Kikuchi","year":"2015","unstructured":"Kikuchi T, Iwabu Y, Tada T, Kawana-Tachikawa A, Koga M, Hosoya N, et al. Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers. J Virol. 2015;89(9):4992\u20135001.","journal-title":"J Virol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-2961-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-2961-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-2961-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T18:12:00Z","timestamp":1693505520000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-2961-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2961"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-2961-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,25]]},"assertion":[{"value":"9 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for the study was obtained from the Research Ethics Committees of the University of KwaZulu-Natal (E013\/04) and University of Cape Town (025\/2004). All participants provided written, informed consent to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to publish was obtained from EC1 and EC2.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors have any competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"54"}}